Christopher Durant Turner

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Nathan McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Durant Turner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvalent, Inc. Chief Medical Officer Class A Common Stock 72,630 $7,305,924 $100.59 07 Jan 2026 Direct
Nuvalent, Inc. Chief Medical Officer Stock Option (Right to Buy) 17,500 07 Jan 2026 Direct

Insider Reports Filed by Christopher Durant Turner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVL Nuvalent, Inc. 05 Jan 2026 9 -$721,320 4 Chief Medical Officer 07 Jan 2026, 17:26
NUVL Nuvalent, Inc. 06 Jan 2025 5 -$320,009 4 Chief Medical Officer 08 Jan 2025, 16:50
NUVL Nuvalent, Inc. 05 Jan 2024 2 $0 4 Chief Medical Officer 09 Jan 2024, 16:55
NUVL Nuvalent, Inc. 04 Oct 2023 8 -$376,945 4 Chief Medical Officer 06 Oct 2023, 16:58
NUVL Nuvalent, Inc. 26 Jul 2023 6 -$206,542 4 Chief Medical Officer 28 Jul 2023, 16:51
NUVL Nuvalent, Inc. 20 Jul 2023 6 -$11,977 4 Chief Medical Officer 24 Jul 2023, 16:54
NUVL Nuvalent, Inc. 05 Jun 2023 3 -$388,623 4 Chief Medical Officer 07 Jun 2023, 16:50
NUVL Nuvalent, Inc. 06 Jan 2023 1 $0 4 Chief Medical Officer 06 Jan 2023, 15:47
NUVL Nuvalent, Inc. 17 May 2022 2 +$99,995 4 Chief Medical Officer 19 May 2022, 16:36
NUVL Nuvalent, Inc. 04 Jan 2022 1 $0 4 Chief Medical Officer 05 Jan 2022, 16:26
NUVL Nuvalent, Inc. 28 Jul 2021 0 $0 3 Chief Medical Officer 28 Jul 2021, 21:30